Skip to main navigation
  • Search Aptevo.com
  • About Us
    • Management Team
    • Board of Directors
  • Our Technology
  • Pipeline
    • APVO436
    • ALG.APV-527
    • APVO603
    • Multiple Candidates
  • Investors

    Investors

    • Stock Details
    • News
    • Events
    • Presentations
    • Financial Reports
    • Corporate Governance
    • Investor FAQ
    • Investor Contacts
  • Careers
ADAPTIR immuno-oncology (I/O) biotech
Aptevo Therapeutics (NYSE:APVO)
Aptevo Therapeutics (NYSE:APVO)
  • Search Aptevo.com
  • About Us
    • Management Team
    • Board of Directors
  • Our Technology
  • Pipeline
    • Mipletamig
    • ALG.APV-527
    • APVO603
    • Multiple Candidates
  • Investors

    Investors

    • Stock Details
    • News
    • Events
    • Presentations
    • Financial Reports
    • Corporate Governance
    • Investor FAQ
    • Investor Contacts
  • Careers

Investors

Corporate Governance

  • Overview
  • Board of Directors
  • Committee Composition
  • Contact the Board

Corporate Governance

Committee Charters
Audit Committee
Nominating and Corporate Governance Committee
Compensation Committee
Governance Documents
Corporate Governance Guidelines
Code of Conduct
2021 CA Declaration of Compliance

Quick Links

  • Stock Details
  • News
  • Events
  • Presentations
  • Financial Reports
  • Analyst Coverage
  • Spin-out Tax Documentation
  • Corporate Governance
  • Investor FAQ
  • Investor Contacts

Tools

  • Print
  • RSS Feeds
  • E-mail Alerts
  • Home
  • About Us
  • Our Technology
  • Pipeline
  • Investors
  • Careers
  • Contact Us
  • Sitemap
  • Privacy Policy
  • Terms of Use
  • Aptevo Terms and Conditions

© 2026 Aptevo Therapeutics